XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS’ EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Common stock, beginning balance (in shares) at Jul. 01, 2022     315          
Beginning balance at Jul. 01, 2022 $ 12,323 $ (37) $ 3 $ 3,733 $ (128) $ (579) $ 9,166 $ 91
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 47           47  
Employee stock plans (in shares)     3          
Employee stock plans (50)     (50)        
Stock-based compensation 86     86        
Foreign currency translation adjustment (87)              
Net unrealized gain (loss) on derivative contracts (60)         (60)    
Common stock, ending balance (in shares) at Sep. 30, 2022     318          
Ending balance at Sep. 30, 2022 12,222   $ 3 3,641   (726) 9,304  
Common stock, beginning balance (in shares) at Jul. 01, 2022     315          
Beginning balance at Jul. 01, 2022 12,323 $ (37) $ 3 3,733 $ (128) (579) 9,166 $ 91
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (404)              
Common stock, ending balance (in shares) at Dec. 30, 2022     319          
Ending balance at Dec. 30, 2022 12,245   $ 3 3,770   (381) 8,853  
Common stock, beginning balance (in shares) at Sep. 30, 2022     318          
Beginning balance at Sep. 30, 2022 12,222   $ 3 3,641   (726) 9,304  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (451)           (451)  
Employee stock plans (in shares)     1          
Employee stock plans 43     43        
Stock-based compensation 86     86        
Foreign currency translation adjustment 117              
Net unrealized gain (loss) on derivative contracts 228         228    
Common stock, ending balance (in shares) at Dec. 30, 2022     319          
Ending balance at Dec. 30, 2022 $ 12,245   $ 3 3,770   (381) 8,853  
Beginning balance (in shares) at Jun. 30, 2023 1              
Beginning balance at Jun. 30, 2023 $ 876              
Ending balance (in shares) at Sep. 29, 2023 1              
Ending balance at Sep. 29, 2023 $ 876              
Common stock, beginning balance (in shares) at Jun. 30, 2023 322   322          
Beginning balance at Jun. 30, 2023 $ 10,964   $ 3 3,936   (548)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (685)           (685)  
Employee stock plans (in shares)     2          
Employee stock plans (43)     (43)        
Stock-based compensation 77     77        
Foreign currency translation adjustment (38)         (38)    
Net unrealized gain (loss) on derivative contracts (45)         (45)    
Common stock, ending balance (in shares) at Sep. 29, 2023     324          
Ending balance at Sep. 29, 2023 $ 10,230   $ 3 3,970   (631) 6,888  
Beginning balance (in shares) at Jun. 30, 2023 1              
Beginning balance at Jun. 30, 2023 $ 876              
Ending balance (in shares) at Dec. 29, 2023 1              
Ending balance at Dec. 29, 2023 $ 876              
Common stock, beginning balance (in shares) at Jun. 30, 2023 322   322          
Beginning balance at Jun. 30, 2023 $ 10,964   $ 3 3,936   (548)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ (972)              
Common stock, ending balance (in shares) at Dec. 29, 2023 326   326          
Ending balance at Dec. 29, 2023 $ 10,068   $ 3 3,957   (493) 6,601  
Beginning balance (in shares) at Sep. 29, 2023 1              
Beginning balance at Sep. 29, 2023 $ 876              
Ending balance (in shares) at Dec. 29, 2023 1              
Ending balance at Dec. 29, 2023 $ 876              
Common stock, beginning balance (in shares) at Sep. 29, 2023     324          
Beginning balance at Sep. 29, 2023 10,230   $ 3 3,970   (631) 6,888  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (287)              
Employee stock plans (in shares)     2          
Employee stock plans 33     33        
Stock-based compensation 72     72        
Purchase of capped calls related to the issuance of convertible notes, net of tax (118)     (118)        
Foreign currency translation adjustment 58         58    
Net unrealized gain (loss) on derivative contracts $ 80         80    
Common stock, ending balance (in shares) at Dec. 29, 2023 326   326          
Ending balance at Dec. 29, 2023 $ 10,068   $ 3 $ 3,957   $ (493) $ 6,601